Showing results (31-40 of 49) with videos related to

Sort By:
Pageof 5
Frontiers in Immunology|December 16, 2022
Prognosis stratification in breast cancer and characterization of immunosuppressive microenvironment through a pyrimidine metabolism-related signatureYongzhou Luo, Wenwen Tian, Xiuqing Lu, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 31, 2013
Structure-based cleavage mechanism of Thermus thermophilus Argonaute DNA guide strand-mediated DNA target cleavageGang Sheng, Hongtu Zhao, Jiuyu Wang, et al.
Frontiers in Psychology|August 28, 2023
COVID-19 symptoms, internet information seeking, and stigma influence post-lockdown health anxietyQian Li, Xue Yang, Xin Wang, et al.
ACS Nano|December 4, 2023
Self-Powered Hydrogen Production with Improved Energy Efficiency via Polysulfides RedoxJin-Tao Ren, Lei Chen, Hao-Yu Wang, et al.
Frontiers in Immunology|October 24, 2022
Turning up a new pattern: Identification of cancer-associated fibroblast-related clusters in TNBCJindong Xie, Shaoquan Zheng, Yutian Zou, et al.
Research (Washington, D.C.)|December 19, 2023
Dissection of FOXO1-Induced LYPLAL1-DT Impeding Triple-Negative Breast Cancer Progression via Mediating hnRNPK/β-Catenin ComplexYuhui Tang, Wenwen Tian, Shaoquan Zheng, et al.
Frontiers in Immunology|April 18, 2022
Prognosis and Dissection of Immunosuppressive Microenvironment in Breast Cancer Based on Fatty Acid Metabolism-Related SignatureYuhui Tang, Wenwen Tian, Jindong Xie, et al.
International Journal of Molecular Sciences|December 23, 2022
The Pan-Cancer Multi-Omics Landscape of FOXO Family Relevant to Clinical Outcome and Drug ResistanceJindong Xie, Junsheng Zhang, Wenwen Tian, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|July 29, 2024
Autophagy Deficiency Induced by SAT1 Potentiates Tumor Progression in Triple-Negative Breast CancerWenwen Tian, Lewei Zhu, Yongzhou Luo, et al.
Clinical and Translational Medicine|February 11, 2023
Dissecting the role of cancer-associated fibroblast-derived biglycan as a potential therapeutic target in immunotherapy resistance: A tumor bulk and single-cell transcriptomic studyShaoquan Zheng, Jie-Ying Liang, Yuhui Tang, et al.
Pageof 5